| Dr Frederic Laporte, M | |
|
750 E Adams St, Syracuse, NY 13210-2342 | |
| (315) 464-2500 | |
| Not Available |
| Full Name | Dr Frederic Laporte |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 750 E Adams St, Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093085433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 273167 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massena Hospital Inc | Massena, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massena Hospital Inc | 1456781491 | 45 |
News Archive
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Dried patterns and cracks from people's blood droplets could indicate specific health conditions, new research suggests.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).
› Verified 8 days ago
| Entity Name | Adirondack Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245446533 PECOS PAC ID: 9638081284 Enrollment ID: O20031103000224 |
News Archive
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Dried patterns and cracks from people's blood droplets could indicate specific health conditions, new research suggests.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).
› Verified 8 days ago
| Entity Name | Champlain Valley Physicians Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124189782 PECOS PAC ID: 2769396878 Enrollment ID: O20031121000623 |
News Archive
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Dried patterns and cracks from people's blood droplets could indicate specific health conditions, new research suggests.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).
› Verified 8 days ago
| Entity Name | Canton-potsdam Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568548782 PECOS PAC ID: 6204827280 Enrollment ID: O20040519000761 |
News Archive
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Dried patterns and cracks from people's blood droplets could indicate specific health conditions, new research suggests.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).
› Verified 8 days ago
| Entity Name | Upstate Emergency Medicine, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275589582 PECOS PAC ID: 2466443494 Enrollment ID: O20040519001106 |
News Archive
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Dried patterns and cracks from people's blood droplets could indicate specific health conditions, new research suggests.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).
› Verified 8 days ago
| Entity Name | Medical Services Of Suffolk County Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811235724 PECOS PAC ID: 8527209246 Enrollment ID: O20130723000586 |
News Archive
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Dried patterns and cracks from people's blood droplets could indicate specific health conditions, new research suggests.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).
› Verified 8 days ago
| Entity Name | Massena Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972604460 PECOS PAC ID: 1456781491 Enrollment ID: O20200515000493 |
News Archive
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Dried patterns and cracks from people's blood droplets could indicate specific health conditions, new research suggests.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frederic Laporte, M 3896 Vertex Path Apt 12, Syracuse, NY 13209-5056 Ph: (315) 450-8678 | Dr Frederic Laporte, M 750 E Adams St, Syracuse, NY 13210-2342 Ph: (315) 464-2500 |
News Archive
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
Dried patterns and cracks from people's blood droplets could indicate specific health conditions, new research suggests.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that it has acquired Ovion intellectual property rights from American Medical Systems Holdings, Inc. for a cash purchase price of $23.6 million.
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).
› Verified 8 days ago
Brennan Ellis, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-6202 Fax: 315-464-9501 | |
Bethany A Hawke, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4363 | |
David J. Seeley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 301 Prospect Ave, Syracuse, NY 13203 Phone: 315-448-5101 | |
Risa L Farber-heath, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4363 Fax: 315-464-8690 | |
Dr. Christopher Thomas Tanski, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4363 Fax: 315-464-4854 | |
Andrey Moyko, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 736 Irving Ave, Syracuse, NY 13210 Phone: 617-754-2323 | |
Michael Timothy Kernan, MD. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Morton Rd Ste 104, Syracuse, NY 13214 Phone: 315-491-4225 Fax: 315-663-0123 |